Li Zhang is a Neurology physician. ClinicalTrials.gov lists 165 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
120 Spalding Dr Ste 101
Naperville, IL 605406599
Telephone
630-527-7730Provider last certified this registry record 4 Feb 2021.
Clinical trials
- Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Kangabio AUSTRALIA LTD PTY
- QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer
Sponsor: Sun Yat-sen University
- Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar Defects
Sponsor: Tang-Du Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Supernus Pharmaceuticals, Inc.Program year20231 payment
- E.R. Squibb & Sons, L.L.C.Program year20211 payment
- AbbVie Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other antiepileptics25.3%Topiramate55%Levetiracetam45%Part D≥14 patientsCholinesterase Inhibitor21.7%Donepezil Hcl100%Part D≥23 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1999–2010 per NIH RePORTER. The latest:
6 awards on record per NIH RePORTER; the itemized rows are on their way. Why? →
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”